World’s first personalized CRISPR therapy given to baby with genetic disease
Posted:
A baby boy with a devastating genetic disease is thriving after becoming the first known person to receive a bespoke, CRISPR therapy-for-one, designed to correct his specific disease-causing mutation.
Little KJ Muldoon, now nearly ten months old, is doing well after receiving three doses of a gene-editing treatment
Technical debt comes in many forms, especially for hospitals and health systems. The larger the organization, the more complex the technology, explains David Hotchkiss, vice president and chief information and security officer for the Medical College of Wisconsin.
Read more here.
Learn how the MHRA and NICE are getting medicines to patients 3 to 6 months sooner by delivering same time decisions on licensing and value.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us